The Anti-Pollution Research Center of Amorepacific R&D Center has developed the world’s first clinical evaluation method for blocking blue light from reaching the skin. The research paper, which involves research on the harmful effects of blue light on the skin, the development of clinical devices, verification of the efficacy of blocking agents and so on, has been published in the Aug. 18, 2020 issue (the 19th issue of 2020) of The Journal of Cosmetic Dermatology, which is the SCI-grade international academic journal.
Blue light is a blue wavelength portion of the visible light spectrum ranging from 380−500 nm (nanometers). Blue light has the shortest wavelength and the strongest energy among all types of visible light, and prolonged exposure to this type of light is known to have harmful effects, such as sleep disturbance and damage to vision.
Blue light can have detrimental effects on the skin as well, including skin pigmentation and reductions in skin elasticity and moisture. Prior to Amorepacific’s research, however, there had not been any clinical research that had concretely proved the harmfulness of everyday blue light exposure to the skin, the company said.
Published via Happi, March 2020
👉 The Skinobs team will be delighted to welcome you booth 857, to talk with…
At Byome Labs, we help cosmetic, dermo-cosmetic and pharmaceutical brands decode the invisible world of…
Nevisense is a non-invasive tool for monitoring skin barrier function with several applications in cosmetic…